drugset / Trial / NCT02151682

A Study to Look at Tapentadol Tablets in Children and Adolescents in Pain

NCT02151682

Phase 2/3 Completed 73 enrolled Grünenthal GmbH
RandomizedParallel-groupOpen-labelTreatment

Summary

Tapentadol has already been studied in adults. This study is needed to find out if tapentadol works and is safe to use in children and adolescents with long-term pain.

Timeline

Start
2015-04-29
Primary completion
2017-10-18
Completion
2018-10-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Morphine Other / unclassified 10 mg Oral
Comparator Morphine Other / unclassified 30 mg Oral
Subject Tapentadol Small molecule 25 mg Oral
Subject Tapentadol Small molecule 100 mg Oral

Indications

No indication recorded.